Novel Agents Targeting Crucial Signalling Pathways in Head and Neck Squamous Cell Carcinoma, HNSCC - Preclinical Development and Data from Clinical Trials

Publisher： Bentham Science Publishers

E-ISSN： 1875-6247|10|2|150-164

ISSN： 1570-1646

Source： Current Proteomics, Vol.10, Iss.2, 2013-07, pp. : 150-164

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NFκB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC)

By  

FEBS Open Bio, Vol. 4, Iss. 1, 2014-01 ,pp. : 96-104

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeting head and neck squamous cell carcinoma using a novel fusion toxin-diphtheria toxin/HN-1

By Potala Sirisha   Verma Rama  

Molecular Biology Reports, Vol. 38, Iss. 2, 2011-02 ,pp. : 1389-1397

Springer Publishing Company

Access to resources Recommend Favorite

Epidermal growth factor receptor (EGFR) mutations as biomarker for head and neck squamous cell carcinomas (HNSCC)

By Nagalakshmi K.   Jamil Kaiser   Pingali Usharani   Reddy M. Vishnuvardhan   Attili Suresh S. V.  

Biomarkers, Vol. 19, Iss. 3, 2014-05 ,pp. : 198-206

Informa Healthcare

Access to resources Recommend Favorite

MET and RON Receptor Tyrosine Kinases: Novel Therapeutic Targets in Squamous Cell Carcinoma of the Head and Neck

By  

Current Enzyme Inhibition, Vol. 3, Iss. 1, 2007-02 ,pp. : 1-12

Bentham Science Publishers

Access to resources Recommend Favorite

Correlation between nitric oxide and cyclooxygenase-2 pathways in head and neck squamous cell carcinomas

By Gallo O.   Fabbroni V.   Sardi I.   Magnelli L.   Boddi V.   Franchi A.  

Biochemical and Biophysical Research Communications, Vol. 299, Iss. 4, 2002-12 ,pp. : 517-524

Elsevier

Access to resources Recommend Favorite